Analytische Chemie
Filtern
Erscheinungsjahr
- 2022 (35) (entfernen)
Dokumenttyp
- Vortrag (11)
- Zeitschriftenartikel (10)
- Posterpräsentation (10)
- Sonstiges (3)
- Forschungsdatensatz (1)
Schlagworte
- Immunoassay (13)
- Antibody (7)
- Biosensor (5)
- Biosensoren (5)
- SARS-CoV-2 (5)
- Amperometry (4)
- ELISA (3)
- Electrochemistry (3)
- Mass Spectrometry (3)
- Amoxicillin (2)
Organisationseinheit der BAM
- 1.8 Umweltanalytik (35) (entfernen)
Eingeladener Vortrag
- nein (11)
In coastal systems, organisms are exposed to amultitude of stressors whose interactions and effects are poorly studied. Pharmaceutical drugs and Climate Change consequences, such as lowered pH, are examples of stressors affecting marine organisms, as bivalves. Although a vast literature is available for the effects of these stressors when acting individually, very limited information exists on the impacts that the combination of both can have on marine bivalves. For this reason, this study aimed to evaluate the impacts of a simulated ocean acidification scenario (control pH, 8.0; lowered pH, pH 7.6) on the effects of the antiepileptic carbamazepine (CBZ, 1 μg/L) and the antihistamine cetirizine (CTZ, 0.6 μg/L), when acting individually and combined (CBZ + CTZ), on the edible clam Ruditapes philippinarum. After 28 days of exposure, drug concentrations, bioconcentration factors and biochemical parameters related to the clams' metabolic capacity and oxidative stress were evaluated. The results showed that R. philippinarum clams responded differently to pharmaceutical drugs depending on the pH tested, influencing both bioconcentration and biological responses. In general, drug combined treatments showed fewer impacts than drugs acting alone, and acidification seemed to activate at a higher extension the elimination processes that were not activated under control pH. Also, lowered pH per se exerted negative impacts (e.g., cellular damage) on R. philippinarum and the combination with pharmaceutical drugs did not enhance the toxicity.
Das Ziel der vorliegenden Arbeit war die rekombinante Herstellung der AnFAO in E. coli, welche ursprünglich von A. niger produziert wird, und deren anschließende Anwendung in der Entwick-lung eines Fumonisin- Biosensors für die Lebensmittelanalytik. In Bezug auf die aktuell steigen-den Lebensmittel- und Rohstoffpreise ist die Entwicklung eines Schnelltestsystems zur Detektion von Kontaminationen mit Mykotoxinen besonders gefragt, da zusätzliche Verluste und Kosten verhindert werden können. Für die Herstellung der AnFAO als MBP-Fusionsprotein und Biotin-Fusionsprotein mit zusätzlichem 6x His-Tag wurden die pET-MBP-AnFAO und pRSET-BH6-An-FAO Expressionsvektoren erfolgreich konstruiert. Die lösliche Expression im Cytoplasma wurde von MBP-AnFAO erreicht, wobei die Expression von BH6-AnFAO in inclusion bodies erfolgte und keine Aktivität des Enzyms nachgewiesen wurde. Die Enzymaktivität von MBP-AnFAO wurde im optischen Assay und amperometrisch durch die Detektion von H2O2 ermittelt. Im optischen Assay wurde die maximale spezifische Aktivität von 2,45 U/mg bei 45 °C, einer Enzymkonzentration von 3 μM und 50 μM FB1 erreicht. Generell wurden mit FB1 als Enzymsubstrat höhere Fluoreszenzsig-nale und dementsprechend höhere Enzymaktivitäten als für FB2 beobachtet. Es wurde ein linearer Zusammenhang der Enzymaktivitäten mit der Substratkonzentration beobachtet. Außerdem wurde ein Anstieg der H2O2-Konzentration mit zunehmender Inkubationszeit (bis zu 60 Minuten) erkannt. Des Weiteren wurde der Einfluss des MBP-Fusionsproteins auf die Enzymaktivität des AnFAO untersucht. Dabei wurde anhand von wesentlich geringeren Aktivitäten für AnFAO allein ein eventueller Einfluss des MBP auf dessen Aktivität festgestellt. Ein elektrochemischer Aufbau wurde zur Entwicklung eines Fumonisin- Sensors genutzt. Dazu wurde nachgewiesen, dass FB1 von rekombinant hergestelltem MBP-AnFAO unter Bildung von NH3 und H2O2 zu weniger toxi-schem FB1, dem FPy1, oxidiert werden kann. An der PB/Kohlenstoff-Elektrode, welche sensitiver gegenüber H2O2 und stabiler als die CoPC/Kohlenstoff Elektrode war, wurde die Reduktion des enzymatisch gebildeten H2O2 gemessen. Die Erstellung einer FB1- Kalibriergerade mit FB1- Lösun-gen verschiedener Konzentrationen zeigte, dass das Enzym auch in immobilisierter Form in der Lage ist unterschiedliche Konzentrationen an FB1 zu desaminieren. Dazu gehört auch der Kon-zentrationsbereich unterhalb des festgelegten Grenzwertes von 2,7 μmol/kg für Fumonisin. Die amperometrischen Kurven hierfür wurden an der PB/Kohlenstoff-Elektrode erfolgreich aufge-nommen. Störungen des H2O2- Redoxstroms durch das Enzym, der Enzymsubstrate und der Ne-benprodukte während der amperometrischen Messung wurden ausgeschlossen. Sowohl im opti-schen als auch im amperometrischen Assay wurde ausschließlich das enzymatisch gebildete H2O2 bestimmt.
High polarity analyte(s) in aqueous media: determination of L-PFOA and L-PFOS in ground water
(2022)
The CCQM-K156 comparison was coordinated by TUBITAK UME on behalf of the Organic Analysis Working Group (OAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) for National Measurement Institutes (NMIs) and Designated Institutes (DIs) which provide measurement services in organic analysis under the 'Comité International des Poids et Mesures' Mutual Recognition Arrangement (CIPM MRA).
Perfluoro alkyl substances (PFAS) such as PFOS and PFOA have been used in numerous industrial applications and products. Because of their high stability and resistance to biodegradation, atmospheric photooxidation, direct photolysis and hydrolysis, they are extremely persistent in the environment. The European Union (EU) Water Framework Directive lists PFOS as a priority hazardous substance that poses a significant risk to the aquatic environment. The use of PFOS-containing Aqueous Film-Forming Foams (AFFFs) has been banned since June 2011 in the EU. As relatively water-soluble, effectively non-degradable compounds, PFOS and PFOA migrate to ground water. They are not removed in the conventional drinking water treatment, and therefore cause health risks in polluted areas. The EU Drinking Water Directive and the European Commission has proposed a limit value of 100 ng/L for the sum of 20 PFAS, including PFOS and PFOA.
This study provides the means for assessing measurement capabilities for determination of high polarity measurands in a procedure that requires extraction, clean-up, analytical separation and detection. Successful participation in CCQM-K156 demonstrates measurement capabilities in determining mass fraction of organic compounds, with a molecular mass of 200 g/mol to 700 g/mol, having high polarity pKow -2, in a mass fraction range from 0.5 ng/kg to 500 ng/kg in aqueous media.
Nine NMIs and DIs participated in the CCQM-K156 key comparison. Seven institutes reported their results. SPE was applied in the sample pre-treatment and LC-MS was applied for detection. All participating laboratories applied isotope dilution mass spectrometry (IDMS) techniques for quantification. Participants established the metrological traceability of their results using certified reference materials (CRMs) from NMIs with stated traceability; where commercially available high purity materials were used the purity was determined in-house. The CCQM-K156 results for L-PFOA and L-PFOS range from 2.75 ng/kg to 5.50 ng/kg with a % RSD of 19.5 % for L-PFOA and from 2.04 ng/kg to 4.45 ng/kg with a % RSD of 21.3 % for L-PFOS. The KCRV was assigned using a Hierarchical Bayesian Random Effects Model (HB REM) estimator from the values reported by six of the participants. One participant result of L-PFOS and one result of L-PFOA were excluded from the KCRV for technical reasons. The KCRV was 4.9 ng/kg ± 0.4 ng/kg for L-PFOA and 3.8 ng/kg ± 0.4 ng/kg for L-PFOS. The six institutes that were included in the assignment of consensus KCRV all agreed within their standard uncertainties.
To reach the main text of this paper, click on Final Report. Note that this text is that which appears in Appendix B of the BIPM key comparison database https://www.bipm.org/kcdb/.
The final report has been peer-reviewed and approved for publication by the CCQM, according to the provisions of the CIPM Mutual Recognition Arrangement (CIPM MRA).
With the development of hybridoma technology, monoclonal antibodies are increasingly important in therapeutic and analytical applications. For recombinant expression in mammalian cells, knowledge of the variable regions of both, heavy (VH) and light (VL) chain, is a necessary prerequisite for generating expression plasmids. Furthermore, cloning antibody sequences including constant regions CH1 to CH3 and CL reduces impact of hybridoma cell loss and associated full natural antibody sequence leakage. Here, we show a cost-effective workflow for amplification of IgG antibody variable regions in combination with advanced methods for full-length cloning of monoclonal antibodies.
The metrological analysis uses an unbroken chain of comparative measurements to trace results back to the national or international standard. This enables comparable, absolute quantification between laboratories. In 2020/2021, a pilot study for the quantification of SARS-CoV-2 antibodies was initiated with the involvement of BAM. Despite the consistent use of ID-MS, a large discrepancy in the results of the participating laboratories was found. This was the motivation for a project to systematically investigate and optimize traceable methods of protein quantification using mass spectrometric nontarget analysis (NTA) and recombinant antibody panels.
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast & cost-effective on-site analyses. Magnetic bead-based immunoassays (MBBAs) allow for implementation into an immunosensor for online testing. Particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically (chronoamperometry) on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.
Contamination of the environment with antibiotics is of great concern as it promotes the evolution of antimicrobial resistances. In case of amoxicillin (AMX) in the aquatic environment, further risk arises from hydrolysis products (HPs) which can cause allergy. To assess these risks, a comprehensive investigation and understanding of the degradation of AMX is necessary. We investigated the hydrolysis rate of AMX in different types of water as well as the influence of temperature and irradiation. The content of the heavy metal ions copper and zinc was found to be crucial for the hydrolysis rate of AMX and stability of HPs. Eventually, a new degradation pathway for AMX could be elaborated and confirmed by tandem mass spectrometry (LC-MS/MS).
Contamination of drinking water with pharmaceuticals is an emerging problem and a potential health threat. Immunochemical methods based on the binding of the analyte to specific antibodies enable fast & cost-effective on-site analyses. Magnetic bead-based immunoassays (MBBAs) allow for implementation into an immunosensor for online testing. Particles are prepared by either coupling the analyte molecule (diclofenac) or the respective antibody (amoxicillin) to the surface. For miniaturization, detection is performed electrochemically (chronoamperometry) on a microfluidic chip. The developed immunosensor will enable detection of pharmaceuticals directly in water supply pipes.
The outbreak of SARS-CoV-2 in December of 2019, led to a worldwide still on-going pandemic. Since then, several so-called waves of SARS-CoV-2 infections, a time period with a high and fast rising number of new infections, have occurred all over the world. Classic surveillance approaches are hardly applicable, and further, non-detected cases cannot be covered by them. Wastewater-based Epidemiology (WBE) was proven to be a reliable tool for the prediction of new SARS-CoV-2 infection waves, due to the discharge of virus particles in fecal shedding of infectious people. Until now, for the monitoring of SARS-CoV-2 in wastewater, Polymerase Chain Reaction (PCR) is used as analytical tool. Even though PCR is a highly sensitive analytical tool, is presents several disadvantages, such as the need for trained personnel, specific technical equipment, as well as a difficult performance. An analytical tool, to which these disadvantaged do not apply, are immunoassays. In this work, a sandwich Enzyme-Linked Immunosorbent Assay (ELISA), with the immobilization of the capture antibodies on the surface of a Microtiter Plate (MTP), as well as a sandwich Magnetic Bead-Based Assay (MBBA), with immobilization of the capture antibodies on the surface of Magnetic Beads (MBs), targeting the SARS-CoV-2 N-protein, were developed and optimized. Both assay formats were performed with a colorimetric and chemiluminescent detection. The developed assay is composed of the two monoclonal antibodies (mAb) AH2 and DE6 - which was biotinylated in the course of the work - which bind to two different epitops of the antigen N-protein. As tracer, Neutravidin-HRP was used, which binds, through interaction of the Neutravidin with the biotin, to the mAb DE6-Biotin. The assay development and optimization procedure included the investigation of the surface saturation with the mAb AH2, the concentration and dilution of the mAb DE6-Biotin and Neutravidin-HRP, the ideal MBs, the ideal coating as well as dilution buffers, and the colorimetric and chemiluminescent substrates. For the developed and fully optimized colorimetric ELISA, a test midpoint x0 of 388 μg/L, for the chemiluminsecent ELISA of 371 μg/L, for the colorimetric MBBA of 251 μg/L and for the chemiluminescent MBBA of 243 μg/L was obtained. Validation of the colorimetric MBBA was done by measurement of three wastewater samples collected at the Wastewater Treatment Plant (WWTP) Potsdam. Whilst no N-protein could be detected in the samples, by spiking of the wastewater samples with certain concentrations of the N-protein, 10- to 18-times lower concentrations could be back-calculated, which can be attributed to matrix-effects of the wastewater sample. Next to the matrix-effects, also several other reason exist, why no N-protein could be determined in the samples. Because of that, further investigation of the handling, and the measurement of the wastewater samples, as well as the improvement of the assay sensitivity through further optimization steps or exchange of the antibodies, is still necessary.
Bisphenol A (BPA) is used in Polycarbonate, Polyacrylic resins, Polysulfones, Epoxy resins, and Polyetherimides. It is also used in recycled Polyvinyl chloride [1–3]. BPA has been classified as a substance of very high concern (SVHC) under REACH [4] due to its endocrine disrupting properties. The German competent authorities want to reduce the content of BPA in the environment. Possible substitutes for BPA are Bisphenol B (BPB), Bisphenol E (BPE),
Bisphenol F (BPF), or Bisphenol S (BPS), as they are similar in structure.
BPA-based materials have a wide area of application especially outside. These outdoor applications are exposed to different external influences, including physical, biological, mechanical and chemical influences. This results in damage and aging of the material with leaching or migration into the environment. There, the substance is transformed by various transformation processes. The emerging metabolites and transformation products (TPs) can have different properties than the parent substance. Understanding the fate and behavior of the emerging pollutants is very important.
Therefore, different transformation products of selected bisphenols will be generated and analyzed:
To investigate the fate of different bisphenols in water treatment plants technical transformation products [5] will be generated by chlorination, ozonization, the Fenton reaction, and UV-radiation.
For the investigation of the fate of Bisphenols in surface water global radiation will be simulated with UVA-lamps
Simulation of phase-I-metabolism with an electrochemical cell coupled to mass spectrometry (EC-MS).